Helen Tedeholm

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs

Helen Tedeholm, Jan Lycke, Bengt Skoog et al. · Multiple Sclerosis Journal · 2012 · 81 citations · Full text

Continuous prediction of secondary progression in the individual course of multiple sclerosis

Bengt Skoog, Helen Tedeholm, Björn Runmarker et al. · Multiple Sclerosis and Related Disorders · 2014 · 56 citations

Secondary Progression, Disease Progression, Neurological Disorder +7

The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset

Helen Tedeholm, Bengt Skoog, Vera Lisovskaja et al. · Journal of Neurology · 2015 · 44 citations

Outcome Spectrum, Neurological Functioning, Disease Progression +7

Diffusion tensor imaging in multiple sclerosis at different final outcomes

Oluf Andersen, Anders Hildeman, Marco Longfils et al. · Acta Neurologica Scandinavica · 2017 · 22 citations

Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis

Helen Tedeholm, Fredrik Piehl, Jan Lycke et al. · Multiple Sclerosis and Related Disorders · 2022 · 12 citations · Full text

Disease Progression, Neurological Disorder, Clinical Trials +6